Literature DB >> 20807839

A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain.

François R Jornayvaz1, Michael J Jurczak, Hui-Young Lee, Andreas L Birkenfeld, David W Frederick, Dongyang Zhang, Xian-Man Zhang, Varman T Samuel, Gerald I Shulman.   

Abstract

Low-carbohydrate, high-fat ketogenic diets (KD) have been suggested to be more effective in promoting weight loss than conventional caloric restriction, whereas their effect on hepatic glucose and lipid metabolism and the mechanisms by which they may promote weight loss remain controversial. The aim of this study was to explore the role of KD on liver and muscle insulin sensitivity, hepatic lipid metabolism, energy expenditure, and food intake. Using hyperinsulinemic-euglycemic clamps, we studied insulin action in mice fed a KD or regular chow (RC). Body composition was assessed by ¹H magnetic resonance spectroscopy. Despite being 15% lighter (P < 0.001) than RC-fed mice because of a 17% increase in energy expenditure (P < 0.001), KD-fed mice manifested severe hepatic insulin resistance, as reflected by decreased suppression (0% vs. 100% in RC-fed mice, P < 0.01) of endogenous glucose production during the clamp. Hepatic insulin resistance could be attributed to a 350% increase in hepatic diacylglycerol content (P < 0.001), resulting in increased activation of PKCε (P < 0.05) and decreased insulin receptor substrate-2 tyrosine phosphorylation (P < 0.01). Food intake was 56% (P < 0.001) lower in KD-fed mice, despite similar caloric intake, and could partly be attributed to a more than threefold increase (P < 0.05) in plasma N-acylphosphatidylethanolamine concentrations. In conclusion, despite preventing weight gain in mice, KD induces hepatic insulin resistance secondary to increased hepatic diacylglycerol content. Given the key role of nonalcoholic fatty liver disease in the development of type 2 diabetes and the widespread use of KD for the treatment of obesity, these results may have potentially important clinical implications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20807839      PMCID: PMC2980360          DOI: 10.1152/ajpendo.00361.2010

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  45 in total

1.  UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality.

Authors:  Helena M Feldmann; Valeria Golozoubova; Barbara Cannon; Jan Nedergaard
Journal:  Cell Metab       Date:  2009-02       Impact factor: 27.287

Review 2.  Obesity and the metabolic syndrome in developing countries.

Authors:  Anoop Misra; Lokesh Khurana
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

3.  Cold-activated brown adipose tissue in healthy men.

Authors:  Wouter D van Marken Lichtenbelt; Joost W Vanhommerig; Nanda M Smulders; Jamie M A F L Drossaerts; Gerrit J Kemerink; Nicole D Bouvy; Patrick Schrauwen; G J Jaap Teule
Journal:  N Engl J Med       Date:  2009-04-09       Impact factor: 91.245

4.  Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man.

Authors:  Constantinos Christodoulides; Pamela Dyson; Dennis Sprecher; Kostas Tsintzas; Fredrik Karpe
Journal:  J Clin Endocrinol Metab       Date:  2009-06-16       Impact factor: 5.958

5.  Diet-induced obese mice are leptin insufficient after weight reduction.

Authors:  Haifei Shi; Shailaja Akunuru; John C Bierman; Karen M Hodge; M Chrissy Mitchell; Michelle T Foster; Randy J Seeley; Ofer Reizes
Journal:  Obesity (Silver Spring)       Date:  2009-04-16       Impact factor: 5.002

6.  Long-term effects of a very-low-carbohydrate weight loss diet compared with an isocaloric low-fat diet after 12 mo.

Authors:  Grant D Brinkworth; Manny Noakes; Jonathan D Buckley; Jennifer B Keogh; Peter M Clifton
Journal:  Am J Clin Nutr       Date:  2009-05-13       Impact factor: 7.045

7.  Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes.

Authors:  Varman T Samuel; Sara A Beddow; Takanori Iwasaki; Xian-Man Zhang; Xin Chu; Christopher D Still; Glenn S Gerhard; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-08       Impact factor: 11.205

8.  FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response.

Authors:  Matthew J Potthoff; Takeshi Inagaki; Santhosh Satapati; Xunshan Ding; Tianteng He; Regina Goetz; Moosa Mohammadi; Brian N Finck; David J Mangelsdorf; Steven A Kliewer; Shawn C Burgess
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-16       Impact factor: 11.205

9.  N-acylphosphatidylethanolamine, a gut- derived circulating factor induced by fat ingestion, inhibits food intake.

Authors:  Matthew P Gillum; Dongyan Zhang; Xian-Man Zhang; Derek M Erion; Rachel A Jamison; Cheolsoo Choi; Jianying Dong; Marya Shanabrough; Hillary R Duenas; David W Frederick; Jennifer J Hsiao; Tamas L Horvath; Chun Min Lo; Pat Tso; Gary W Cline; Gerald I Shulman
Journal:  Cell       Date:  2008-11-28       Impact factor: 41.582

10.  Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.

Authors:  Alberto O Chavez; Marjorie Molina-Carrion; Muhammad A Abdul-Ghani; Franco Folli; Ralph A Defronzo; Devjit Tripathy
Journal:  Diabetes Care       Date:  2009-06-01       Impact factor: 19.112

View more
  85 in total

1.  Activation of the farnesoid X receptor induces hepatic expression and secretion of fibroblast growth factor 21.

Authors:  Holly A Cyphert; Xuemei Ge; Alison B Kohan; Lisa M Salati; Yanqiao Zhang; F Bradley Hillgartner
Journal:  J Biol Chem       Date:  2012-06-01       Impact factor: 5.157

2.  Thyroid hormone receptor-α gene knockout mice are protected from diet-induced hepatic insulin resistance.

Authors:  François R Jornayvaz; Hui-Young Lee; Michael J Jurczak; Tiago C Alves; Fitsum Guebre-Egziabher; Blas A Guigni; Dongyan Zhang; Varman T Samuel; J Enrique Silva; Gerald I Shulman
Journal:  Endocrinology       Date:  2011-12-06       Impact factor: 4.736

Review 3.  Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease.

Authors:  Rebecca C Schugar; Peter A Crawford
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-07       Impact factor: 4.294

4.  Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes.

Authors:  Leigh Goedeke; Rachel J Perry; Gerald I Shulman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

5.  Adaptive changes in amino acid metabolism permit normal longevity in mice consuming a low-carbohydrate ketogenic diet.

Authors:  Nicholas Douris; Tamar Melman; Jordan M Pecherer; Pavlos Pissios; Jeffrey S Flier; Lewis C Cantley; Jason W Locasale; Eleftheria Maratos-Flier
Journal:  Biochim Biophys Acta       Date:  2015-07-11

Review 6.  Central nervous system regulation of brown adipose tissue.

Authors:  Shaun F Morrison; Christopher J Madden
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

7.  A bioenergetics systems evaluation of ketogenic diet liver effects.

Authors:  Lewis J Hutfles; Heather M Wilkins; Scott J Koppel; Ian W Weidling; J Eva Selfridge; Eephie Tan; John P Thyfault; Chad Slawson; Aron W Fenton; Hao Zhu; Russell H Swerdlow
Journal:  Appl Physiol Nutr Metab       Date:  2017-05-17       Impact factor: 2.665

8.  Low-carbohydrate, high-fat diets have sex-specific effects on bone health in rats.

Authors:  Ayse Zengin; Benedikt Kropp; Yan Chevalier; Riia Junnila; Elahu Sustarsic; Nadja Herbach; Flaminia Fanelli; Marco Mezzullo; Stefan Milz; Martin Bidlingmaier; Maximilian Bielohuby
Journal:  Eur J Nutr       Date:  2015-09-19       Impact factor: 5.614

9.  Methionine and choline regulate the metabolic phenotype of a ketogenic diet.

Authors:  Pavlos Pissios; Shangyu Hong; Adam Richard Kennedy; Deepthi Prasad; Fen-Fen Liu; Eleftheria Maratos-Flier
Journal:  Mol Metab       Date:  2013-07-08       Impact factor: 7.422

Review 10.  Endocrine causes of nonalcoholic fatty liver disease.

Authors:  Laura Marino; François R Jornayvaz
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.